RedHill Biopharma Ltd (RDHL)

[toddski]

Couple of things. First, all three phase three drugs they are moving along were purchased from bankrupt entities for cheap. Doesn't mean they are junk, just they are good businessmen and the street doesn't get that. Secondly, they are Israeli based and do not get the benefit of the doubt. You will not find another company this under valued that is us based and has this many drugs in pipeline and this much potential.

What hurts in the short run here certainly is the massive 30 percent dilution they just did. Time will tell if that was truly necessary and if it will pay off in the long term. I think bekinda will be approved for gastroenteritis and they will be using their Donnatal salesman to market it. Rizaport should be submitted for nda soon and they will self market this as well. Baby steps. You could be watching the slow growth of a giant redwood tree here.

Take a look at ICPT back in 2014. What occurred there was a trial stopping short due to overwhelming efficacy. I think their drug was for Nash. Does that sound familiar to you? It went from 15/sh to over 400/sh in a year. Rhb-104 could have a similar effect if stopped early for overwhelming efficacy.